SCHEMBL2863679

SCHEMBL2863679

COC(=O)c1ccc2[nH]nc(-c3cc4ccccc4s3)c2c1F

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
JAK2 O60674 1/20 0.44
JAK3 P52333 1/20 0.44
MAPK10 P53779 1/20 0.42
MAPKAPK2 P49137 1/20 0.41
SIRT2 Q8IXJ6 1/20 0.40
SIRT1 Q96EB6 1/20 0.40
TNIK Q9UKE5 5/20 0.39
SLC6A3 Q01959 1/20 0.39
PIP5K1C O60331 1/20 0.39
MAP2K4 P45985 1/20 0.36
PAK4 O96013 1/20 0.35
CSNK2A2 P19784 1/20 0.35
AKT1 P31749 1/20 0.35
PLK1 P53350 1/20 0.35
CSNK2B P67870 1/20 0.35
CSNK2A1 P68400 1/20 0.35
ITK Q08881 1/20 0.35
ALDH1A1 P00352 1/20 0.35
KDM4E B2RXH2 1/20 0.35
STAT3 P40763 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2859049 0.87 MAPK10 (0.43) JAK2JAK3MAPK10MAPKAPK2SIRT2
SCHEMBL4332488 0.82 MAPK10 (0.39) JAK2JAK3MAPK10MAPKAPK2SIRT2
SCHEMBL2857326 0.82 PIP5K1C (0.48) MAPK10MAPKAPK2SIRT2SIRT1PIP5K1C
SCHEMBL13198255 0.82 SIRT2 (0.40) JAK2JAK3MAPK10MAPKAPK2SIRT2
SCHEMBL13198256 0.80 TRPV3 (0.44) JAK2JAK3MAPK10MAPKAPK2SIRT2
SCHEMBL4336807 0.80 TRPV3 (0.44) JAK2JAK3MAPK10MAPKAPK2SIRT2
SCHEMBL2857820 0.80 ACLY (0.42) JAK2JAK3MAPK10MAPKAPK2SIRT2
SCHEMBL2867525 0.80 ALPL (0.50) JAK2JAK3MAPKAPK2SLC6A3MAP2K4
Cyclopropanecarboxylic Acid Amide SCHEMBL2857322 0.79 SIRT2 (0.48) JAK2JAK3MAPK10MAPKAPK2SIRT2
SCHEMBL4343390 0.78 HPGD (0.45) ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7776890-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-08-17 US disclosed
EP-1380576-B1 1H-INDAZOLE COMPOUNDS INHIBITING JNK EISAI R&D MAN CO LTD (JP) 2009-11-25 EP disclosed
US-20090203691-A1 Novel 1H-indazole compounds OINUMA HITOSHI 2009-08-13 US disclosed
US-7541376-B2 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-06-02 US disclosed
US-6982274-B2 1H-indazole compound EISAI CO., LTD. (JP) 2006-01-03 US disclosed
US-20050282880-A1 Novel 1H-indazole compounds EISAI R&D MANAGEMENT CO., LTD. (JP) 2005-12-22 US disclosed
US-20040127538-A1 Novel 1h-indazole compound EISAI R&D MANAGEMENT CO., LTD. (JP) 2004-07-01 US disclosed
EP-1380576-A1 NOVEL 1H-INDAZOLE COMPOUND Eisai Co., Ltd. (JP) 2004-01-14 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (3 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090203691-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 JAK2 145/4885JAK3 776/4885MAPK10 29/4885
US-20040127538-A1 Novel 1h-indazole compound MAPK1, MAPK14, MAPK3 JAK2 247/4885JAK3 743/4885MAPK10 27/4885
US-20050282880-A1 Novel 1H-indazole compounds MAPK1, MAPK3, MAPK13 JAK2 145/4885JAK3 776/4885MAPK10 29/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.